Form EFFECT iTeos Therapeutics, Inc.

September 5, 2025 6:03 AM UTC
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 4, 2025
Accession Number: 0001140361-25-033424
Submission Type: POS AM
CIK: 0001808865
Company Name: iTeos Therapeutics, Inc.
File Number: 333-271793


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings